During the past decade, Clinique Pasteur-Toulouse-Atrium conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Clinique Pasteur-Toulouse-Atrium" are "Cancer" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Clinique Pasteur-Toulouse-Atrium" in a lesser frequency.

Most popular intervention types in "Clinique Pasteur-Toulouse-Atrium" are "Drug" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Degarelix" (1 trials), "Radiotherapy" (1 trials) and "approved GnRH agonist" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinique Pasteur-Toulouse-Atrium" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Clinique Pasteur-Toulouse-Atrium". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Clinique Pasteur-Toulouse-Atrium, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clinique Pasteur-Toulouse-Atrium, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".